Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $192.44 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $66.59 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $53.68 | 2 | $0 (2024) |
| AbbVie, Inc. | $45.21 | 2 | $0 (2017) |
| Galderma Laboratories, L.P. | $14.41 | 1 | $0 (2024) |
| Incyte Corporation | $12.55 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68.09 | 3 | Regeneron Healthcare Solutions, Inc. ($53.68) |
| 2022 | $12.55 | 1 | Incyte Corporation ($12.55) |
| 2019 | $66.59 | 5 | Novartis Pharmaceuticals Corporation ($66.59) |
| 2017 | $45.21 | 2 | AbbVie, Inc. ($45.21) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.41 | General |
| 05/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2022 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $12.55 | General |
| Category: Hematology/Oncology | ||||||
| 08/06/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: DERMATOLOGY | ||||||
| 07/26/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: DERMATOLOGY | ||||||
| 06/24/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: DERMATOLOGY | ||||||
| 04/25/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Immunology | ||||||
| 03/30/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,248 | 1,941 | $310,193 | $156,946 |
| 2022 | 12 | 989 | 1,595 | $237,246 | $119,630 |
| 2021 | 12 | 897 | 1,317 | $218,725 | $112,669 |
| 2020 | 9 | 561 | 740 | $116,361 | $57,605 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 287 | $53,659 | $27,053 | 50.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 184 | 282 | $46,792 | $24,488 | 52.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 97 | 152 | $37,549 | $20,205 | 53.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 151 | 151 | $36,672 | $19,057 | 52.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 24 | 28 | $27,813 | $14,831 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 206 | $27,174 | $13,033 | 48.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 138 | 162 | $23,977 | $10,470 | 43.7% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 15 | 15 | $13,950 | $7,439 | 53.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 14 | 18 | $10,818 | $6,030 | 55.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 94 | 119 | $11,654 | $3,817 | 32.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 63 | 93 | $6,863 | $3,811 | 55.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $6,512 | $3,110 | 47.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 67 | 371 | $3,632 | $1,982 | 54.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 17 | $3,128 | $1,618 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 274 | $51,512 | $25,695 | 49.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 156 | 221 | $36,907 | $19,638 | 53.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 121 | 121 | $29,524 | $15,558 | 52.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 73 | 117 | $29,133 | $15,275 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 146 | $19,418 | $9,859 | 50.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 15 | 17 | $16,796 | $8,993 | 53.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 117 | 137 | $20,687 | $8,781 | 42.4% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 12 | 12 | $11,136 | $5,765 | 51.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 87 | 103 | $10,197 | $3,620 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $4,756 | $2,408 | 50.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 68 | 372 | $3,720 | $2,076 | 55.8% |
About Dr. Robert Lin, DO
Dr. Robert Lin, DO is a MOHS-Micrographic Surgery healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1033466487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lin, DO has received a total of $192.44 in payments from pharmaceutical and medical device companies, with $68.09 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($192.44).
As a Medicare-enrolled provider, Lin has provided services to 3,695 Medicare beneficiaries, totaling 5,593 services with total Medicare billing of $446,850. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Houston, TX
- Active Since 08/03/2012
- Last Updated 06/12/2024
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033466487
Products in Payments
- COSENTYX (Biological) $66.59
- LIBTAYO (Biological) $53.68
- Humira (Biological) $45.21
- JAKAFI (Drug) $12.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in Houston
Dr. Paul Friedman, M.d, M.D
MOHS-Micrographic Surgery — Payments: $133,080
Dr. Christopher Downing, M.d, M.D
MOHS-Micrographic Surgery — Payments: $9,240
Janet Li, M.d, M.D
MOHS-Micrographic Surgery — Payments: $8,336
Mr. Jeremiah Au, M.d, M.D
MOHS-Micrographic Surgery — Payments: $7,555
Dr. Erik Petersen, M.d, M.D
MOHS-Micrographic Surgery — Payments: $1,113
Bruce Nelson, M.d, M.D
MOHS-Micrographic Surgery — Payments: $216.95